Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NICHD

A Carboxypeptidase E-delta N-terminus Splice Variant Used To Predict And Detect Tumor Metastasis. AND Carboxypeptidase E-gammaN Biomarker For Determining Metastasis And Predicting Recurrence Of Paragangliomas And Differentiated Thyroid Carcinomas

  • Read more about A Carboxypeptidase E-delta N-terminus Splice Variant Used To Predict And Detect Tumor Metastasis. AND Carboxypeptidase E-gammaN Biomarker For Determining Metastasis And Predicting Recurrence Of Paragangliomas And Differentiated Thyroid Carcinomas
Patent Cooperation Treaty
PCT/US2009/050460
Filed on 2009-07-14

A New Vaccine For Shigella Sonnei That Is The Leading Cause Of Shigella In The U.S. And In Most Developed Countries World-wide

  • Read more about A New Vaccine For Shigella Sonnei That Is The Leading Cause Of Shigella In The U.S. And In Most Developed Countries World-wide
Patent Cooperation Treaty
PCT/US2009/053897
Filed on 2009-08-14

Detection and Quantification of HIV Antigen

  • Read more about Detection and Quantification of HIV Antigen
Patent Cooperation Treaty
PCT/US09/051440
Filed on 2009-07-22

Stabilization Of Complexes For GeI Mobility Shift, Chromatography, And Capillary Electrophoresis

  • Read more about Stabilization Of Complexes For GeI Mobility Shift, Chromatography, And Capillary Electrophoresis
US Application 12/485,481
Filed on 2009-06-16

Orally Active Peptides that Prevent Cell Damage and Death

  • Read more about Orally Active Peptides that Prevent Cell Damage and Death
Luxembourg
00957607.5
Filed on 2000-08-17

Orally Active Peptides that Prevent Cell Damage and Death

  • Read more about Orally Active Peptides that Prevent Cell Damage and Death
Ireland
00957607.5
Filed on 2000-08-17

GOSSYPOL FOR THE TREATMENT OF CANCER

  • Read more about GOSSYPOL FOR THE TREATMENT OF CANCER
US Application 12/426,841
Filed on 2009-04-20

17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as Antiprogestational Agents

  • Read more about 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as Antiprogestational Agents
European Patent
08009259.6
Filed on 2001-03-16

21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS

  • Read more about 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Canada
2668824
Filed on 1997-04-30

Biomarkers for niemann-pick C disease and related disorders

  • Read more about Biomarkers for niemann-pick C disease and related disorders
US Patent 8,497,122
Filed on 2009-04-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 78
  • Page 79
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • …
  • Next page ››
  • Last page Last »
Subscribe to NICHD
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health